MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -7.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | -4 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | — | — |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | — | — |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | — | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | — |
| Q2 2024 | 10 | — | 22.76M | $556.69M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.27M | -4.7% | $46.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.59M | -23.5% | $40.73M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 3 | Millennium Management ✦ | 4.07M | -6.3% | $36.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Glenview Capital ✦ | 3.90M | -6.2% | $34.59M | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 2.52M | +38.6% | $22.38M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passive) | 2.23M | +4.1% | $19.79M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Fisher Asset Management ✦ | 1.08M | +18.8% | $9.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 535.13K | -30.1% | $4.75M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 433.39K | +278.9% | $3.84M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 10 | Renaissance Technologies ✦ | 249.77K | -63.5% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 185.00K | -46.9% | $1.64M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 48.15K | +9.2% | $428,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 14.50K | New | $128,615 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $128,615 | 0.0% |
Exited
| Arrowstreet Capital | $2.10M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 200 holders, 87.60M shares, $371.14M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.